Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to $1.7 million.

  • CV Sciences' Cost of Revenue fell 1964.54% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year decrease of 930.98%. This contributed to the annual value of $8.5 million for FY2024, which is 428.3% down from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Cost of Revenue is $1.7 million, which was down 1964.54% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Cost of Revenue ranged from a high of $3.4 million in Q4 2021 and a low of $1.7 million during Q3 2025
  • Over the past 5 years, CV Sciences' median Cost of Revenue value was $2.2 million (recorded in 2023), while the average stood at $2.4 million.
  • In the last 5 years, CV Sciences' Cost of Revenue crashed by 4167.06% in 2021 and then surged by 3238.13% in 2022.
  • Over the past 5 years, CV Sciences' Cost of Revenue (Quarter) stood at $3.4 million in 2021, then tumbled by 31.32% to $2.3 million in 2022, then decreased by 10.75% to $2.1 million in 2023, then increased by 7.19% to $2.2 million in 2024, then decreased by 24.01% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.8 million for Q2 2025, and $1.9 million during Q1 2025.